pharmacy

Benzinga’s weekly Stock Wars matches up two leaders in a major industry sector, with the goal of determining which company is the better investment. This week, the duel is between a pair of pharmacy retail chains: CVS Health Corp (NYSE: CVS) and Walgreens Boots Alliance Inc (NASDAQ...

If you have traveled through towns and cities in the U.S. with small populations, you have likely seen the trend of Dollar General Corp. (NYSE: DG) stores popping up there. The retailer has capitalized on a business plan of serving these sometimes overlooked communities. New plans...

Starbucks Corporation (NASDAQ: SBUX) has lost its COO Rosalind Brewer, who accepted the CEO title at Walgreens Boots Alliance Inc (NASDAQ: WBA). What Happened: Brewer was the CEO of Sam's Club before joining Starbucks as COO and member of the board. She played a leadership role in shifting...

Shares of pharmacy retailer Walgreens Boots Alliance Inc (NASDAQ: WBA) ended 2020 lower by nearly 30%, but Baird sees several catalysts for the company that it said should put an end to years of "train wreck" performance. The Walgreens Analyst: Eric Coldwell upgraded...

  Walgreens Boots Alliance Inc (NASDAQ: WBA) disclosed on Wednesday that it had signed an agreement with healthcare products distributor AmerisourceBergen Corp (NYSE: ABC) to sell a majority stake in its Alliance Healthcare business. The deal is valued at $6....

Teladoc Health (NASDAQ: TDOC) is falling with news out that Amazon.com (NASDAQ: AMZN) is entering the telehealth space. What Happened: Business Insider is out with a report Wednesday that Amazon is working on efforts to build a national telehealth business. The efforts would be geared toward...

The two largest pharmacy chains in the U.S. have grown through unit expansion and several major acquisitions. The companies have seen their share prices fall on concerns surrounding Amazon.com's entry into the market. Benzinga is looking at how CVS Health Corporation (NYSE: CVS)...

Prescription delivery is one of the business sectors that's been spotlighted by the coronavirus pandemic.  Even ahead of the pandemic, this space was seen as one with potential. Drugs are commodities, and pharma companies are defensive plays that tend to do well even during a downturn...

Walgreens Boots Alliance Inc (NASDAQ: WBA) has struggled in 2020, but its problems started well before the COVID-19 economic disruption. The stock is now down 52.3% over the last five years, and BofA Securities analyst Michael Cherny said Wednesday there’s little reason to expect...

CVS Health Corp's (NYSE: CVS) second-quarter earnings report can be defined as "more good than bad" yet the stock still trades at a discounted valuation, according to BofA Securities. The CVS Analyst: Michael Cherny maintains a Buy rating on CVS with an $80 price target. The...

The Dow Jones Industrial Average came 400 points of falling to the 20,000 mark Monday, and even after a minor rebound, the index is still down a massive 2,000 points, or more than 9%. Two Dow components were standing out amid the wreckage: Caterpillar Inc. (NYSE: CAT) and Walgreens Boots...

Walgreens Boots Alliance Inc (NASDAQ: WBA) is reportedly evaluating an offer to sell itself to private equity giant KKR, and Warren Buffett could insert himself into the saga, a portfolio manager told CNBC Tuesday.  Wall Street analysts and the financial media community are almost unified in...

Pharmacy retail chain Walgreens Boots Alliance Inc (NASDAQ: WBA) closed Wednesday at a valuation of $55 billion, but it could be worth $85 billion under a leveraged buyout, according to Fox Business. Analyst Models $75-Per-Share Buyout  Private equity giant KKR reportedly expressed interest in...

Diplomat Pharmacy Inc (NYSE: DPLO) cautioned investors on Tuesday that it has "substantial doubts" related to its ability to continue functioning as a business. Some analysts aren't ready to throw in the towel just yet — and see upside after Tuesday's all-time lows...

Shares of Diplomat Pharmacy, Inc. (NYSE: DPLO), a Flint, Michigan-based independent provider of specialty pharmacy and infusion services, plummeted more than 50% Tuesday after the company warned investors it faces an existential threat.  What Happened Diplomat reported third-quarter...